At T1, obesity was associated with a 2-fold increase of myeloid cell chemoattractants CCL2 (Figure 1G) and 1.5-fold increase in circulating CCL4. The gene discussed is CCL2; the disease is obesity due to melanocortin 4 receptor deficiency.